CareDx (CDNA) Misses Q3 EPS by 4c

CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $7.34 million.

CareDx confirmed its revenue guidance for the full year 2015 of $28 to $30 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• Marchex (MCHX) Reports In-Line Q2 EPS